Global Postmenopausal Osteoporosis Treatment Market Size study & Forecast, by Drug Type (Bisphosphonates, Vitamin D3, Estrogen Agonist/Antagonist, Hormone Replacement Therapy, Parathyroid Hormone Therapy, Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Others) and Regional Analysis, 2023-2030
Global Postmenopausal Osteoporosis Treatment Market is valued approximately at USD 9.12 billion in 2022 and is anticipated to grow with a growth rate of more than 5.2% over the forecast period 2023-2030. Postmenopausal osteoporosis is a condition that occurs in women after menopause, typically in their 50s or 60s. It is a type of osteoporosis that is caused by the decrease in estrogen levels that occurs during menopause. Estrogen is an important hormone for maintaining bone density and when levels drop, bones can become weaker and more brittle, leading to an increased risk of fractures. The Postmenopausal Osteoporosis Treatment market is expanding because of factors such as increasing Prevalence of Osteoporosis and growing geriatric population.
One of the risk factors for poor bone density and the subsequent development of osteoporosis in women after menopause is ageing. Other risk factors include smoking, drinking alcohol, using gonadotropins, thyroid hormone in excess and using other medications used to treat various conditions. According to data from the International Menopause Society (IMS), Osteoporosis has affect more than 200 million women on a global level in 2021, and one in three women over 50 is predicted to have an osteoporosis fracture. The postmenopausal osteoporosis market has grown significantly as a result of the ageing population and lifestyle changes. The older population is more susceptible to osteoporosis, their population growth is anticipated to be a major driving force behind the market's expansion. In the World Health Organization's October 2021 report, for instance, it is predicted that the number of adults 60 and older will rise from 1 billion in 2020 to 1.4 billion by 2030 and 2.1 billion by 2050. The need for treatment of postmenopausal osteoporosis in the elderly population is thus expected to rise during the forecast period, leading to market growth. In addition, rising research and development activities and rapid technological development and continuing clinical trials is creating lucrative growth to the market. However, high Cost of Postmenopausal osteoporosis treatment and low awareness about postmenopausal osteoporosis stifles market growth throughout the forecast period of 2023-2030.
The key regions considered for the Global Postmenopausal Osteoporosis Treatment Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 with largest market share owing to the dominance of branded treatment and the region's increasing disease prevalence. Asia Pacific is expected to grow significantly during the forecast period, owing to factors such as rising geriatric and target populations, an increase in the number of collaborations for treatment development, geographic expansion of key players, and active participation of government and nonprofit organizations in the market space.
Major market player included in this report are:
Teva Pharmaceuticals Industries Ltd.
Pfizer Inc.
Merck & Co.
Novartis AG
Eli Lilly and Company
AbbVie (Allergan plc.)
F. Hoffmann-La Roche Ltd.
Cipla Inc.
Amgen Inc.
Sun Pharmaceutical Industries Ltd
Recent Developments in the Market:
In June 2022, Chugai Pharma China Co., Ltd., a branch of Chugai Pharmaceutical Co., Ltd., launched Edirol (eldecalcitol) in China after receiving permission from the China National Medical Products Administration (NMPA) for the treatment of postmenopausal osteoporosis. Chugai created Edirol, a derivative of active vitamin D3.
In January 2021, The Asia Pacific Consortium on Osteoporosis (APCO) has proposed pan-Asia Pacific clinical practise standards that will primarily target a wide range of high-risk individuals in order to screen, diagnose, and manage osteoporosis. The plan is anticipated to further increase regional awareness, which will aid in the expansion of the Asia-Pacific market.
Global Postmenopausal Osteoporosis Treatment Market Report Scope:
Historical Data – 2020 - 2021
Base Year for Estimation – 2022
Forecast period - 2023-2030
Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered - Drug Type, Distribution Channel, Region
Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Customization Scope - Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Drug Typeofferings of key players. The detailed segments and sub-segment of the market are explained below:
By Drug Type:
Bisphosphonates
Vitamin D3
Estrogen Agonist/Antagonist
Hormone Replacement Therapy
Parathyroid Hormone Therapy
Others
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa
One of the risk factors for poor bone density and the subsequent development of osteoporosis in women after menopause is ageing. Other risk factors include smoking, drinking alcohol, using gonadotropins, thyroid hormone in excess and using other medications used to treat various conditions. According to data from the International Menopause Society (IMS), Osteoporosis has affect more than 200 million women on a global level in 2021, and one in three women over 50 is predicted to have an osteoporosis fracture. The postmenopausal osteoporosis market has grown significantly as a result of the ageing population and lifestyle changes. The older population is more susceptible to osteoporosis, their population growth is anticipated to be a major driving force behind the market's expansion. In the World Health Organization's October 2021 report, for instance, it is predicted that the number of adults 60 and older will rise from 1 billion in 2020 to 1.4 billion by 2030 and 2.1 billion by 2050. The need for treatment of postmenopausal osteoporosis in the elderly population is thus expected to rise during the forecast period, leading to market growth. In addition, rising research and development activities and rapid technological development and continuing clinical trials is creating lucrative growth to the market. However, high Cost of Postmenopausal osteoporosis treatment and low awareness about postmenopausal osteoporosis stifles market growth throughout the forecast period of 2023-2030.
The key regions considered for the Global Postmenopausal Osteoporosis Treatment Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 with largest market share owing to the dominance of branded treatment and the region's increasing disease prevalence. Asia Pacific is expected to grow significantly during the forecast period, owing to factors such as rising geriatric and target populations, an increase in the number of collaborations for treatment development, geographic expansion of key players, and active participation of government and nonprofit organizations in the market space.
Major market player included in this report are:
Teva Pharmaceuticals Industries Ltd.
Pfizer Inc.
Merck & Co.
Novartis AG
Eli Lilly and Company
AbbVie (Allergan plc.)
F. Hoffmann-La Roche Ltd.
Cipla Inc.
Amgen Inc.
Sun Pharmaceutical Industries Ltd
Recent Developments in the Market:
In June 2022, Chugai Pharma China Co., Ltd., a branch of Chugai Pharmaceutical Co., Ltd., launched Edirol (eldecalcitol) in China after receiving permission from the China National Medical Products Administration (NMPA) for the treatment of postmenopausal osteoporosis. Chugai created Edirol, a derivative of active vitamin D3.
In January 2021, The Asia Pacific Consortium on Osteoporosis (APCO) has proposed pan-Asia Pacific clinical practise standards that will primarily target a wide range of high-risk individuals in order to screen, diagnose, and manage osteoporosis. The plan is anticipated to further increase regional awareness, which will aid in the expansion of the Asia-Pacific market.
Global Postmenopausal Osteoporosis Treatment Market Report Scope:
Historical Data – 2020 - 2021
Base Year for Estimation – 2022
Forecast period - 2023-2030
Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered - Drug Type, Distribution Channel, Region
Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Customization Scope - Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Drug Typeofferings of key players. The detailed segments and sub-segment of the market are explained below:
By Drug Type:
Bisphosphonates
Vitamin D3
Estrogen Agonist/Antagonist
Hormone Replacement Therapy
Parathyroid Hormone Therapy
Others
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa
CHAPTER 1. EXECUTIVE SUMMARY
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1. Postmenopausal Osteoporosis Treatment Market, by region, 2020-2030 (USD Billion)
1.2.2. Postmenopausal Osteoporosis Treatment Market, by Drug Type, 2020-2030 (USD Billion)
1.2.3. Postmenopausal Osteoporosis Treatment Market, by Distribution Channel, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL POSTMENOPAUSAL OSTEOPOROSIS TREATMENT MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL POSTMENOPAUSAL OSTEOPOROSIS TREATMENT MARKET DYNAMICS
3.1. Postmenopausal Osteoporosis Treatment Market Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Increasing Prevalence of Osteoporosis
3.1.1.2. Growing Geriatric Population
3.1.2. Market Challenges
3.1.2.1. High Cost of Postmenopausal Osteoporosis Treatment
3.1.2.2. Low Awareness About Postmenopausal Osteoporosis
3.1.3. Market Opportunities
3.1.3.1. Rising research and development activities
3.1.3.2. Rapid technological development and continuing clinical trials
CHAPTER 4. GLOBAL POSTMENOPAUSAL OSTEOPOROSIS TREATMENT MARKET: INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economic
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
CHAPTER 5. GLOBAL POSTMENOPAUSAL OSTEOPOROSIS TREATMENT MARKET, BY DRUG TYPE
5.1. Market Snapshot
5.2. Global Postmenopausal Osteoporosis Treatment Market by Drug Type, Performance - Potential Analysis
5.3. Global Postmenopausal Osteoporosis Treatment Market Estimates & Forecasts by Drug Type 2020-2030 (USD Billion)
5.4. Postmenopausal Osteoporosis Treatment Market, Sub Segment Analysis
5.4.1. Bisphosphonates
5.4.2. Vitamin D3
5.4.3. Oestrogen Agonist/Antagonist
5.4.4. Hormone Replacement Therapy
5.4.5. Parathyroid Hormone Therapy
5.4.6. Others
CHAPTER 6. GLOBAL POSTMENOPAUSAL OSTEOPOROSIS TREATMENT MARKET, BY DISTRIBUTION CHANNEL
6.1. Market Snapshot
6.2. Global Postmenopausal Osteoporosis Treatment Market by Distribution Channel, Performance - Potential Analysis
6.3. Global Postmenopausal Osteoporosis Treatment Market Estimates & Forecasts by Distribution Channel 2020-2030 (USD Billion)
6.4. Postmenopausal Osteoporosis Treatment Market, Sub Segment Analysis
6.4.1. Hospital Pharmacies
6.4.2. Retail Pharmacies
6.4.3. Others
CHAPTER 7. GLOBAL POSTMENOPAUSAL OSTEOPOROSIS TREATMENT MARKET, REGIONAL ANALYSIS
7.1. Top Leading Countries
7.2. Top Emerging Countries
7.3. Postmenopausal Osteoporosis Treatment Market, Regional Market Snapshot
7.4. North America Postmenopausal Osteoporosis Treatment Market
7.4.1. U.S. Postmenopausal Osteoporosis Treatment Market
7.4.1.1. Drug Type breakdown estimates & forecasts, 2020-2030
7.4.1.2. Distribution Channel breakdown estimates & forecasts, 2020-2030
7.4.2. Canada Postmenopausal Osteoporosis Treatment Market
7.5. Europe Postmenopausal Osteoporosis Treatment Market Snapshot
7.5.1. U.K. Postmenopausal Osteoporosis Treatment Market
7.5.2. Germany Postmenopausal Osteoporosis Treatment Market
7.5.3. France Postmenopausal Osteoporosis Treatment Market
7.5.4. Spain Postmenopausal Osteoporosis Treatment Market
7.5.5. Italy Postmenopausal Osteoporosis Treatment Market
7.5.6. Rest of Europe Postmenopausal Osteoporosis Treatment Market
7.6. Asia-Pacific Postmenopausal Osteoporosis Treatment Market Snapshot
7.6.1. China Postmenopausal Osteoporosis Treatment Market
7.6.2. India Postmenopausal Osteoporosis Treatment Market
7.6.3. Japan Postmenopausal Osteoporosis Treatment Market
7.6.4. Australia Postmenopausal Osteoporosis Treatment Market
7.6.5. South Korea Postmenopausal Osteoporosis Treatment Market
7.6.6. Rest of Asia Pacific Postmenopausal Osteoporosis Treatment Market
7.7. Latin America Postmenopausal Osteoporosis Treatment Market Snapshot
7.7.1. Brazil Postmenopausal Osteoporosis Treatment Market
7.7.2. Mexico Postmenopausal Osteoporosis Treatment Market
7.8. Middle East & Africa Postmenopausal Osteoporosis Treatment Market
7.8.1. Saudi Arabia Postmenopausal Osteoporosis Treatment Market
7.8.2. South Africa Postmenopausal Osteoporosis Treatment Market
7.8.3. Rest of Middle East & Africa Postmenopausal Osteoporosis Treatment Market
CHAPTER 8. COMPETITIVE INTELLIGENCE
8.1. Key Company SWOT Analysis
8.1.1. Company
8.1.2. Company
8.1.3. Company
8.2. Top Market Strategies
8.3. Company Profiles
8.3.1. Teva Pharmaceuticals Industries Ltd.
8.3.1.1. Key Information
8.3.1.2. Overview
8.3.1.3. Financial (Subject to Data Availability)
8.3.1.4. Product Summary
8.3.1.5. Recent Developments
8.3.2. Pfizer Inc.
8.3.3. Merck & Co.
8.3.4. Novartis AG
8.3.5. Eli Lilly and Company
8.3.6. AbbVie (Allergan plc.)
8.3.7. F. Hoffmann-La Roche Ltd.
8.3.8. Cipla Inc.
8.3.9. Amgen Inc.
8.3.10. Sun Pharmaceutical Industries Ltd
CHAPTER 9. RESEARCH PROCESS
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption
LIST OF TABLES
TABLE 1. Global Postmenopausal Osteoporosis Treatment Market, report scope
TABLE 2. Global Postmenopausal Osteoporosis Treatment Market estimates & forecasts by Region 2020-2030 (USD Billion)
TABLE 3. Global Postmenopausal Osteoporosis Treatment Market estimates & forecasts by Drug Type 2020-2030 (USD Billion)
TABLE 4. Global Postmenopausal Osteoporosis Treatment Market estimates & forecasts by Distribution Channel 2020-2030 (USD Billion)
TABLE 5. Global Postmenopausal Osteoporosis Treatment Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 6. Global Postmenopausal Osteoporosis Treatment Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 7. Global Postmenopausal Osteoporosis Treatment Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 8. Global Postmenopausal Osteoporosis Treatment Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 9. Global Postmenopausal Osteoporosis Treatment Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 10. Global Postmenopausal Osteoporosis Treatment Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 11. Global Postmenopausal Osteoporosis Treatment Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 12. Global Postmenopausal Osteoporosis Treatment Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 13. Global Postmenopausal Osteoporosis Treatment Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 14. Global Postmenopausal Osteoporosis Treatment Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 15. U.S. Postmenopausal Osteoporosis Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 16. U.S. Postmenopausal Osteoporosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 17. U.S. Postmenopausal Osteoporosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 18. Canada Postmenopausal Osteoporosis Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 19. Canada Postmenopausal Osteoporosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 20. Canada Postmenopausal Osteoporosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 21. UK Postmenopausal Osteoporosis Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 22. UK Postmenopausal Osteoporosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 23. UK Postmenopausal Osteoporosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 24. Germany Postmenopausal Osteoporosis Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 25. Germany Postmenopausal Osteoporosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 26. Germany Postmenopausal Osteoporosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 27. France Postmenopausal Osteoporosis Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 28. France Postmenopausal Osteoporosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 29. France Postmenopausal Osteoporosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 30. Italy Postmenopausal Osteoporosis Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 31. Italy Postmenopausal Osteoporosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 32. Italy Postmenopausal Osteoporosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 33. Spain Postmenopausal Osteoporosis Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 34. Spain Postmenopausal Osteoporosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 35. Spain Postmenopausal Osteoporosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 36. RoE Postmenopausal Osteoporosis Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 37. RoE Postmenopausal Osteoporosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 38. RoE Postmenopausal Osteoporosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 39. China Postmenopausal Osteoporosis Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 40. China Postmenopausal Osteoporosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 41. China Postmenopausal Osteoporosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 42. India Postmenopausal Osteoporosis Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 43. India Postmenopausal Osteoporosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 44. India Postmenopausal Osteoporosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 45. Japan Postmenopausal Osteoporosis Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 46. Japan Postmenopausal Osteoporosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 47. Japan Postmenopausal Osteoporosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 48. South Korea Postmenopausal Osteoporosis Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 49. South Korea Postmenopausal Osteoporosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 50. South Korea Postmenopausal Osteoporosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 51. Australia Postmenopausal Osteoporosis Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 52. Australia Postmenopausal Osteoporosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 53. Australia Postmenopausal Osteoporosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 54. RoAPAC Postmenopausal Osteoporosis Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 55. RoAPAC Postmenopausal Osteoporosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 56. RoAPAC Postmenopausal Osteoporosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 57. Brazil Postmenopausal Osteoporosis Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 58. Brazil Postmenopausal Osteoporosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 59. Brazil Postmenopausal Osteoporosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 60. Mexico Postmenopausal Osteoporosis Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 61. Mexico Postmenopausal Osteoporosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 62. Mexico Postmenopausal Osteoporosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 63. RoLA Postmenopausal Osteoporosis Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 64. RoLA Postmenopausal Osteoporosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 65. RoLA Postmenopausal Osteoporosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 66. Saudi Arabia Postmenopausal Osteoporosis Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 67. South Africa Postmenopausal Osteoporosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 68. RoMEA Postmenopausal Osteoporosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 69. List of secondary sources, used in the study of global Postmenopausal Osteoporosis Treatment Market
TABLE 70. List of primary sources, used in the study of global Postmenopausal Osteoporosis Treatment Market
TABLE 71. Years considered for the study
TABLE 72. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
TABLE 1. Global Postmenopausal Osteoporosis Treatment Market, report scope
TABLE 2. Global Postmenopausal Osteoporosis Treatment Market estimates & forecasts by Region 2020-2030 (USD Billion)
TABLE 3. Global Postmenopausal Osteoporosis Treatment Market estimates & forecasts by Drug Type 2020-2030 (USD Billion)
TABLE 4. Global Postmenopausal Osteoporosis Treatment Market estimates & forecasts by Distribution Channel 2020-2030 (USD Billion)
TABLE 5. Global Postmenopausal Osteoporosis Treatment Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 6. Global Postmenopausal Osteoporosis Treatment Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 7. Global Postmenopausal Osteoporosis Treatment Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 8. Global Postmenopausal Osteoporosis Treatment Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 9. Global Postmenopausal Osteoporosis Treatment Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 10. Global Postmenopausal Osteoporosis Treatment Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 11. Global Postmenopausal Osteoporosis Treatment Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 12. Global Postmenopausal Osteoporosis Treatment Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 13. Global Postmenopausal Osteoporosis Treatment Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 14. Global Postmenopausal Osteoporosis Treatment Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 15. U.S. Postmenopausal Osteoporosis Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 16. U.S. Postmenopausal Osteoporosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 17. U.S. Postmenopausal Osteoporosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 18. Canada Postmenopausal Osteoporosis Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 19. Canada Postmenopausal Osteoporosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 20. Canada Postmenopausal Osteoporosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 21. UK Postmenopausal Osteoporosis Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 22. UK Postmenopausal Osteoporosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 23. UK Postmenopausal Osteoporosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 24. Germany Postmenopausal Osteoporosis Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 25. Germany Postmenopausal Osteoporosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 26. Germany Postmenopausal Osteoporosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 27. France Postmenopausal Osteoporosis Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 28. France Postmenopausal Osteoporosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 29. France Postmenopausal Osteoporosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 30. Italy Postmenopausal Osteoporosis Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 31. Italy Postmenopausal Osteoporosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 32. Italy Postmenopausal Osteoporosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 33. Spain Postmenopausal Osteoporosis Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 34. Spain Postmenopausal Osteoporosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 35. Spain Postmenopausal Osteoporosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 36. RoE Postmenopausal Osteoporosis Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 37. RoE Postmenopausal Osteoporosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 38. RoE Postmenopausal Osteoporosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 39. China Postmenopausal Osteoporosis Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 40. China Postmenopausal Osteoporosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 41. China Postmenopausal Osteoporosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 42. India Postmenopausal Osteoporosis Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 43. India Postmenopausal Osteoporosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 44. India Postmenopausal Osteoporosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 45. Japan Postmenopausal Osteoporosis Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 46. Japan Postmenopausal Osteoporosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 47. Japan Postmenopausal Osteoporosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 48. South Korea Postmenopausal Osteoporosis Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 49. South Korea Postmenopausal Osteoporosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 50. South Korea Postmenopausal Osteoporosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 51. Australia Postmenopausal Osteoporosis Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 52. Australia Postmenopausal Osteoporosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 53. Australia Postmenopausal Osteoporosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 54. RoAPAC Postmenopausal Osteoporosis Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 55. RoAPAC Postmenopausal Osteoporosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 56. RoAPAC Postmenopausal Osteoporosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 57. Brazil Postmenopausal Osteoporosis Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 58. Brazil Postmenopausal Osteoporosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 59. Brazil Postmenopausal Osteoporosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 60. Mexico Postmenopausal Osteoporosis Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 61. Mexico Postmenopausal Osteoporosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 62. Mexico Postmenopausal Osteoporosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 63. RoLA Postmenopausal Osteoporosis Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 64. RoLA Postmenopausal Osteoporosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 65. RoLA Postmenopausal Osteoporosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 66. Saudi Arabia Postmenopausal Osteoporosis Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 67. South Africa Postmenopausal Osteoporosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 68. RoMEA Postmenopausal Osteoporosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 69. List of secondary sources, used in the study of global Postmenopausal Osteoporosis Treatment Market
TABLE 70. List of primary sources, used in the study of global Postmenopausal Osteoporosis Treatment Market
TABLE 71. Years considered for the study
TABLE 72. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
LIST OF FIGURES
FIG 1. Global Postmenopausal Osteoporosis Treatment Market, research methodology
FIG 2. Global Postmenopausal Osteoporosis Treatment Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Postmenopausal Osteoporosis Treatment Market, key trends 2022
FIG 5. Global Postmenopausal Osteoporosis Treatment Market, growth prospects 2023-2030
FIG 6. Global Postmenopausal Osteoporosis Treatment Market, porters 5 force model
FIG 7. Global Postmenopausal Osteoporosis Treatment Market, pest analysis
FIG 8. Global Postmenopausal Osteoporosis Treatment Market, value chain analysis
FIG 9. Global Postmenopausal Osteoporosis Treatment Market by segment, 2020 & 2030 (USD Billion)
FIG 10. Global Postmenopausal Osteoporosis Treatment Market by segment, 2020 & 2030 (USD Billion)
FIG 11. Global Postmenopausal Osteoporosis Treatment Market by segment, 2020 & 2030 (USD Billion)
FIG 12. Global Postmenopausal Osteoporosis Treatment Market by segment, 2020 & 2030 (USD Billion)
FIG 13. Global Postmenopausal Osteoporosis Treatment Market by segment, 2020 & 2030 (USD Billion)
FIG 14. Global Postmenopausal Osteoporosis Treatment Market, regional snapshot 2020 & 2030
FIG 15. North America Postmenopausal Osteoporosis Treatment Market 2020 & 2030 (USD Billion)
FIG 16. Europe Postmenopausal Osteoporosis Treatment Market 2020 & 2030 (USD Billion)
FIG 17. Asia pacific Postmenopausal Osteoporosis Treatment Market 2020 & 2030 (USD Billion)
FIG 18. Latin America Postmenopausal Osteoporosis Treatment Market 2020 & 2030 (USD Billion)
FIG 19. Middle East & Africa Postmenopausal Osteoporosis Treatment Market 2020 & 2030 (USD Billion)
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
FIG 1. Global Postmenopausal Osteoporosis Treatment Market, research methodology
FIG 2. Global Postmenopausal Osteoporosis Treatment Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Postmenopausal Osteoporosis Treatment Market, key trends 2022
FIG 5. Global Postmenopausal Osteoporosis Treatment Market, growth prospects 2023-2030
FIG 6. Global Postmenopausal Osteoporosis Treatment Market, porters 5 force model
FIG 7. Global Postmenopausal Osteoporosis Treatment Market, pest analysis
FIG 8. Global Postmenopausal Osteoporosis Treatment Market, value chain analysis
FIG 9. Global Postmenopausal Osteoporosis Treatment Market by segment, 2020 & 2030 (USD Billion)
FIG 10. Global Postmenopausal Osteoporosis Treatment Market by segment, 2020 & 2030 (USD Billion)
FIG 11. Global Postmenopausal Osteoporosis Treatment Market by segment, 2020 & 2030 (USD Billion)
FIG 12. Global Postmenopausal Osteoporosis Treatment Market by segment, 2020 & 2030 (USD Billion)
FIG 13. Global Postmenopausal Osteoporosis Treatment Market by segment, 2020 & 2030 (USD Billion)
FIG 14. Global Postmenopausal Osteoporosis Treatment Market, regional snapshot 2020 & 2030
FIG 15. North America Postmenopausal Osteoporosis Treatment Market 2020 & 2030 (USD Billion)
FIG 16. Europe Postmenopausal Osteoporosis Treatment Market 2020 & 2030 (USD Billion)
FIG 17. Asia pacific Postmenopausal Osteoporosis Treatment Market 2020 & 2030 (USD Billion)
FIG 18. Latin America Postmenopausal Osteoporosis Treatment Market 2020 & 2030 (USD Billion)
FIG 19. Middle East & Africa Postmenopausal Osteoporosis Treatment Market 2020 & 2030 (USD Billion)
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
